Form4insider filings, from the source

SEC Form 4 · accession 0001387131-15-001056

TherapeuticsMD, Inc. · TXMD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Tommy G Thompson
Director · Other
Period of report
Mar 25, 2015
Accepted (ET)
Mar 27, 2015 · 4:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000025743

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Non-qualified stock optionF1$5.92Mar 25, 2015A125,000ADec 31, 2015Mar 24, 2025Common Stock125,000125,000I

Explanation of responses